A case of porphyria cutanea terda (PCT) occurring after bone marrow transplantation (BMT) is reported. A 43-year-oid male with chronic myelogenous leukemia received an human leukocyte antigen (HLA)-identical allogeneic transplantation with T-cell depleted marrow. Because of graft rejection, a second
Improved survival of patients with chronic myelogenous leukemia undergoing allogeneic bone marrow transplantation
โ Scribed by Jan Moreb; Thomas Johnson; Paul Kubilis; Lesley Myers; David Oblon; Alan Miller; Gerald Elfenbein; Roy Weiner
- Publisher
- John Wiley and Sons
- Year
- 1995
- Tongue
- English
- Weight
- 236 KB
- Volume
- 50
- Category
- Article
- ISSN
- 0361-8609
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
The role of allogeneic marrow transplantation as treatment of myeloproliferative disorders other than chronic myelogenous leukemia is not yet determined. At our center, 1 patient with primary myelofibrosis, 1 with mastocytosis, and 4 with myeloid metaplasia have been transplanted using HLA-identical
Clinical studies have shown that patients with chronic myeloid leukaemia (CML) treated with allogeneic bone-marrow transplantation (BMT) experience not only prolonged disease-free survival but also complete cure in some. Therefore, we followed a cohort of 81 Chinese patients who received allogeneic